دورية أكاديمية
Managed Care after Acute Myocardial Infarction (MC-AMI) — Poland’s nationwide program of comprehensive post-MI care improves prognosis in 2-year follow-up. A single high-volume center intention-to-treat analysis
| العنوان: | Managed Care after Acute Myocardial Infarction (MC-AMI) — Poland’s nationwide program of comprehensive post-MI care improves prognosis in 2-year follow-up. A single high-volume center intention-to-treat analysis |
|---|---|
| المؤلفون: | Kułach, Andrzej, Wilkosz, Katarzyna, Wybraniec, Maciej, Wieczorek, Piotr, Gąsior, Zbigniew, Mizia-Stec, Katarzyna, Wojakowski, Wojciech, Zdrojewski, Tomasz, Wojtyniak, Bogdan, Gąsior, Mariusz, Wita, Krystian |
| المصدر: | Kardiologia Polska; Vol 81, No 2 (2023); 123-131 ; Kardiologia Polska (Polish Heart Journal); Vol 81, No 2 (2023); 123-131 |
| بيانات النشر: | Polish Cardiac Society |
| سنة النشر: | 2023 |
| المجموعة: | Via Medica Journals |
| مصطلحات موضوعية: | cardiac rehabilitation, cardiovascular prevention, intention-to-treat analysis, myocardial infarction, post-MI prognosis |
| الوصف: | Background: Managed Care in Acute Myocardial Infarction (MC-AMI) is a program introduced in Poland aimed at comprehensive, scheduled, and supervised care for AMI patients to improve longterm prognosis.Aims: Our study aimed to compare 24-month mortality and the incidence of major cardiovascular events (MACE: a composite of death, recurrent MI, and hospitalization for heart failure) in a cohort of AMI patients treated in the MC-AMI era (intention-to-treat analysis) vs. similar population treated before the MC-AMI era.Methods: We analyzed 2323 consecutive patients with AMI: 1261 patients enrolled in the MC-AMI era (study group) and 1062 patients treated 12 months before the MC-AMI era (control group). In the study group, 57% of patients participated in MC-AMI while 43% of patients remained under standard care. The patients were followed up for 24 months. Mortality and MACE were recorded.Results: Treatment in the MC-AMI era was related to a 30% reduction in all-cause mortality and a 14% reduction of MACE although it was not related to the reduction of hospitalization for heart failure (HF) or AMI in 24 months. The 24-month survival rate was the highest in MC-AMI enrolled patients while patients treated in the MC-AMI era but not enrolled had a similar prognosis to those treated before the MC-AMI era. Multivariable Cox regression analysis revealed the MC-AMI era to be inversely associated with mortality in 24-month follow-up (hazard ratio [HR], 0.49; 95% confidence interval [Cl], 0.38–0.65; P <0.001).Conclusions: AMI treatment in the MC-AMI era reduces 24-month mortality and MACE. Moreover, AMI treatment in MC-AMI is inversely related to mortality, MACE, and hospitalization for HF. The effect is pronounced in patients enrolled in MC-AMI. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| العلاقة: | https://journals.viamedica.pl/kardiologia_polska/article/view/KP.a2022.0260Test |
| DOI: | 10.33963/KP.a2022.0260 |
| الإتاحة: | https://doi.org/10.33963/KP.a2022.0260Test https://journals.viamedica.pl/kardiologia_polska/article/view/KP.a2022.0260Test |
| حقوق: | Przesyłając manuskrypt wraz z ilustracjami i tabelami, automatycznie i nieodpłatnie przenosi (przenoszą) na Polskie Towarzystwo Kardiologiczne wszelkie prawa autorskie do wydawania oraz rozpowszechniania nadesłanych materiałów we wszystkich znanych formach i na wszystkich znanych polach eksploatacji, bez ograniczeń terytorialnych językowych pod warunkiem, że materiały te zostaną zaakceptowane do publikacji. ; The copyright to the submitted manuscript is held by the Author, who grants the Polish Cardiac Society a nonexclusive licence to use, reproduce, and distribute the work, including for commercial purposes. Kardiol Pol in an open access journal applying the Creative Commonst Attribution-Non Commercial-No Derivates 4.0 International Licence (CC BY-NC-ND 4.0), allowing third parties to download articles and share them with others, provided the original work is properly cited, not changed in any way, distributed under the same licence, and used for noncommercial purposes only. For commercial use, please contact the journal office: kardiologiapolska@ptkardio.pl. |
| رقم الانضمام: | edsbas.C04E4614 |
| قاعدة البيانات: | BASE |
| DOI: | 10.33963/KP.a2022.0260 |
|---|